- Home
- »
- Medical Devices
- »
-
Fixed And Mobile C-arms Market Size Report, 2026-2033GVR Report cover
Fixed And Mobile C-arms Market (2026 - 2033)
Size, Share & Trends Analysis Report By Product (Fixed C-arms, Mobile C-arms), By Application (Neurosurgery, Cardiovascular, Orthopedics and Trauma, Gastroenterology), By Region, And Segment Forecasts
Market Size, 2025
$3.4BMarket Estimate, 2026
$3.6BMarket Forecast, 2033
$4.9BCAGR, 2026–2033
4.5%Fixed And Mobile C-arms Market Summary
The global fixed and mobile c-arms market size was valued at USD 3.4 billion in 2025 and is projected to grow from USD 3.6 billion in 2026 to USD 4.9 billion by 2033, at a CAGR of 4.5% from 2026 to 2033. The market in North America dominated with a revenue share of 39.6% in 2025. Rising number of surgical procedures, growing demand for minimally invasive surgeries, technological advancements, the increasing prevalence of chronic disorders, and the expanding global geriatric population are key factors contributing to the industry growth.

Key Market Trends & Insights
- By product: Fixed c-arms segment held the largest market share of 59.1% in 2025.
- By application: Orthopedics and trauma segment held the largest market share of 26.8% in 2025.
Regional Highlights.
- Largest regional market: North America (39.6% revenue share, 2025)
- Fastest-growing regional market: Asia Pacific (highest CAGR, 2026-2033)
- By country: The U.S. held the largest market share in 2025
Market Size & Forecast
- Market size in 2025: USD 3.4 Billion
- Estimated market size in 2026: USD 3.6 Billion
- Projected market size by 2033: USD 4.9 Billion
- CAGR (2026-2033): 4.5%
For instance, the WHO states that by 2030, one in six people globally will be aged 60 years or older. Using C-arm systems in intraoperative procedures has become increasingly essential because they provide high-resolution, real-time imaging that enhances surgical precision and patient outcomes. These systems are particularly valuable in complex procedures where accurate visualization of anatomical structures is essential. The growing adoption of minimally invasive surgeries, prioritizing smaller incisions, reduced recovery times, and lower risk of complications further drive growth in the fixed and mobile C-arms industry. These surgeries often require precise imaging guidance, so C-arm systems are important in operating rooms.
In addition, technological advancements, such as improved image quality, reduced radiation exposure, and enhanced system mobility, are significantly contributing to the widespread use of these systems, making them more efficient and accessible for various surgical applications. In March 2024, Siemens Healthineers introduced an advanced, automated, self-driving C-arm system designed for intraoperative imaging in surgery. The Cios Move features holonomic, omnidirectional wheels that enable precise maneuvering, even in confined spaces, and allow for easy and accurate positioning. The system can be moved to pre-set positions at the touch of a button using a remote control, significantly reducing the workload for technologists who previously had to adjust these positions manually.
The growing prevalence of chronic disorders is also contributing to the expansion of fixed and mobile C-arms industry, as these conditions frequently require advanced imaging for diagnosis, treatment planning, and surgical interventions. Chronic disorders such as cardiovascular diseases, cancer, diabetes, orthopedic conditions like osteoporosis or arthritis, and neurological disorders like Parkinson’s disease or strokes often necessitate surgical procedures where precise intraoperative imaging is required.
Market Concentration & Characteristics
The fixed and mobile C-arms industry is accelerating at a moderate pace, driven by technological advancements and the increasing adoption of these advanced devices by end users across healthcare settings. The rising prevalence of the geriatric population, who are more susceptible to a range of disorders such as cardiovascular diseases, orthopedic conditions, and degenerative illnesses, is further propelling industry demand. This demographic trend underscores the need for imaging solutions like C-arms to support effective diagnosis, treatment planning, and surgical interventions.
Companies strategically focus on partnerships and collaborations to enhance their position and broaden their competitive advantage. By teaming up with key stakeholders, including healthcare providers, technology innovators, and research institutions, they aim to drive innovation, expand their product offerings, and address emerging healthcare challenges. This collaborative approach allows them to stay ahead of industry trends, improve service delivery, and better meet the growing demand for advanced medical technologies. For instance, in November 2023, Cleveland Clinic and Canon Inc. announced plans to establish a strategic research partnership to develop advanced imaging and healthcare IT technologies. The collaboration aims to enhance diagnostic capabilities, improve patient care, and achieve better health outcomes by leveraging innovative medical imaging and information technology solutions.

The degree of innovation in the fixed and mobile C-arms industry is high, driven by advancements in imaging technology, miniaturization of components, and the increasing demand for more precise and efficient surgical tools. In January 2022, Philips announced the integration of cloud-based AI and 3D mapping technology into its Mobile C-arm System Series, Zenition, to enhance workflow efficiency and improve endovascular treatment outcomes.
Industry players engage in partnerships and collaborations to strengthen their industry positions and enhance innovation. For instance, in October 2023, Ziehm Imaging announced a partnership with Body Vision Medical in bronchoscopy. Body Vision Medical revealed the successful validation of its LungVision system with Ziehm Imaging's entire product line, including the Ziehm Solo FD and the Ziehm Vision RFD 2D and 3D mobile C-arms.
The impact of regulations on fixed and mobile C-arms is significant, as they must comply with strict safety and quality standards to ensure patient safety and effective performance. Regulatory bodies such as the FDA (U.S. Food and Drug Administration) and the European Medicines Agency (EMA) enforce guidelines on device approval, radiation safety, and operational protocols.
Manufacturers are expanding the reach of their products by growing the installation base of their new offerings. For instance, in September 2024, Tahoe Forest Health System in Truckee, California, became the first healthcare facility in the U.S. to install the Ciartic Move, a fully motorized mobile C-arm from Siemens Healthineers featuring self-driving capabilities.
The fixed and mobile C-arms industry's geographical reach is experiencing moderate to high growth, driven by increasing demand for advanced imaging solutions across various healthcare sectors. This expansion is fueled by rising healthcare infrastructure investments, growing awareness of advanced medical technologies, and the increasing prevalence of chronic diseases requiring precise surgical interventions.
Market Dynamics
The fixed and mobile C-arms market is gaining significant traction as hospitals, ambulatory surgical centers, specialty clinics, trauma centers, and academic medical institutions increasingly adopt advanced intraoperative imaging technologies to support a wide range of diagnostic and image-guided surgical procedures. These systems encompass a broad range of products and technologies, including fixed C-arms, full-size mobile C-arms, mini C-arms, flat-panel detector C-arms, image intensifier-based systems, 3D imaging platforms, and hybrid operating room imaging solutions equipped with advanced visualization and navigation capabilities.
These imaging systems enable healthcare professionals to achieve real-time anatomical visualization, enhanced procedural accuracy, reduced surgical complications, and improved patient outcomes. Fixed and mobile C-arms help healthcare providers diagnose and treat conditions across orthopedics, trauma care, cardiovascular interventions, pain management, neurosurgery, gastroenterology, urology, and vascular procedures. Increasing emphasis on minimally invasive surgery, image-guided interventions, hybrid operating rooms, and procedural precision is driving the adoption of advanced C-arm technologies across healthcare settings.
The fixed and mobile C-arms market is expanding rapidly due to the increasing volume of minimally invasive surgical procedures and the growing need for real-time intraoperative imaging worldwide. Aging populations, rising prevalence of orthopedic disorders, cardiovascular diseases, trauma injuries, spinal conditions, and chronic pain syndromes are contributing to a growing demand for image-guided interventions. Procedures such as fracture fixation, joint replacement, cardiac catheterization, endovascular interventions, spinal surgeries, and pain management treatments increasingly rely on C-arm imaging for procedural guidance and precision.
Furthermore, healthcare providers are increasingly adopting minimally invasive techniques because they reduce surgical trauma, shorten hospital stays, minimize complications, and improve patient recovery. Fixed and mobile C-arms provide continuous fluoroscopic imaging and high-quality visualization, enabling clinicians to accurately position instruments, implants, and devices during procedures. Technological advancements such as flat-panel detector technology, 3D imaging capabilities, dose reduction software, digital image processing, robotic surgery integration, and AI-assisted imaging are further enhancing clinical efficiency and procedural outcomes. As healthcare systems continue emphasizing precision-guided interventions and value-based care, demand for advanced C-arm systems is expected to grow substantially.
Despite strong growth potential, the fixed and mobile C-arms market faces challenges associated with high equipment costs and radiation exposure concerns. Advanced fixed C-arm systems, hybrid operating room installations, and next-generation mobile C-arms with flat-panel detectors often require substantial capital investment, making adoption difficult for smaller hospitals, ambulatory surgical centers, and healthcare facilities operating under budget constraints.
Additionally, concerns regarding cumulative radiation exposure for both patients and healthcare professionals remain an important challenge. Healthcare facilities must invest in radiation protection measures, operator training programs, monitoring systems, and compliance with stringent safety regulations, which can increase overall operational costs. Maintenance requirements, software upgrades, equipment calibration, and service contracts further contribute to the total cost of ownership. In developing regions, limited healthcare infrastructure, inadequate reimbursement support, and shortages of trained interventional specialists may restrict market penetration. These factors can slow adoption rates despite the critical role of C-arm systems in modern image-guided surgical and interventional procedures.
Analyst Perspective
The fixed and mobile C-arms market is driven by the rising burden of orthopedic, cardiovascular, neurological, and chronic pain conditions, increasing surgical volumes, and advances in intraoperative imaging. Growing demand for procedural precision, fewer complications, and better patient outcomes is creating opportunities for imaging manufacturers, healthcare providers, and surgical centers. The increasing adoption of minimally invasive and image-guided procedures is further supporting market growth. Advanced C-arms with flat-panel detectors, 3D imaging, AI-assisted visualization, dose reduction, and hybrid operating room integration are improving workflow efficiency, accuracy, and real-time decision-making. Rising investments in interventional infrastructure and precision-guided therapies are expected to sustain market growth across hospitals, ambulatory surgical centers, and specialty care facilities worldwide.
Product Insights
Based on product, the fixed C-arms segment led the market with the largest revenue share of 59.1% in 2025. Fixed C-arms are particularly adopted in large hospitals and surgical centers for complex procedures that require continuous and precise imaging. Their ability to provide detailed, real-time imaging for a range of medical applications, including orthopedics, cardiology, and neurology, contributes to market growth. Furthermore, technological advancements and integrating features like 3D imaging and AI further boost segment growth.
Mobile C-arms is expected to grow at the fastest CAGR of 4.7% over the forecast period. This growth can be attributed to the flexibility of mobile C-arms, which can be easily moved around the patient to achieve optimal angles for high-quality imaging, all while ensuring the patient's comfort. This mobility is a key advantage over fixed systems, particularly in dynamic and time-sensitive environments. Moreover, continuous technological advancements, such as integrating motorized axes, enhance the ease of movement and positioning, further driving the segment's growth. These innovations allow for more efficient workflow, reduce the need for manual adjustments, and improve imaging precision during procedures.
End Use Insights
Hospital dominated the market by capturing a share of 46.3% in 2024. This is due to the high demand for advanced imaging technologies in hospitals, where C-arms are extensively used for various orthopedic, cardiovascular, and trauma surgeries. Hospitals are major users of fixed and mobile C-arm systems, requiring accurate, real-time imaging to ensure precise surgical interventions and enhance patient outcomes. The presence of comprehensive healthcare services and the need for top-quality diagnostic and surgical equipment further boosts the hospital segment's dominant position in the C-arm market.
The ambulatory surgical centers segment is expected to grow fastest over the forecast period. This growth can be attributed to patients' increasing preference for ASCs due to their cost-effectiveness, convenience, and shorter recovery times compared to traditional hospitals. As patient demand for these centers continues to rise, many ASCs are adopting advanced technologies, including C-arms, to enhance their diagnostic and surgical capabilities. This shift towards state-of-the-art equipment is expected to further drive this segment.
Application Insights
Based on application, orthopedics and trauma led the market with the largest revenue share of 26.8% in 2025. This is due to the extensive use of C-arm systems in orthopedic procedures, including fracture management, joint replacement surgeries, and spinal operations. C-arms provide real-time, high-quality imaging, critical for precise positioning and guidance during these surgeries. Moreover, the growing incidence of musculoskeletal disorders, trauma-related injuries, and an aging population are driving the demand for advanced imaging solutions in orthopedic and trauma care. According to the International Osteoporosis Foundation (IOF), hip fracture rates are projected to increase significantly by 2050, with rates in men expected to rise by 310% and rates in women by 240%, compared to the levels observed in 1990.

The cardiovascular segment is expected to grow at the fastest CAGR of over 4.9% during the forecast period. This is due to the rising prevalence of cardiovascular diseases, including coronary artery disease, heart failure, and arrhythmias, which are leading causes of morbidity and mortality globally. The increasing need for minimally invasive diagnostic and interventional procedures, such as angioplasty and stenting, further contributes to the demand for advanced imaging technologies like C-arms. These systems enable real-time, high-resolution imaging during cardiovascular procedures, improving precision and outcomes while minimizing patient risk. As the global burden of cardiovascular conditions continues to rise, the demand for effective imaging solutions is expected to grow, fueling the expansion of the fixed and mobile C-arms industry.
Regional Insights
North America dominated the fixed and mobile C-arms market with the largest revenue share of 39.6% in 2025. Advancements in technology, such as improved imaging quality, enhanced mobility, and integration with advanced features like 3D mapping and AI, significantly contribute to market growth. Furthermore, the rising geriatric population, which is more prone to chronic disorders and requires surgical interventions, is further fuelling demand for C-arm systems in this region.

U.S. Fixed And Mobile C-arms Market Trends
The fixed and mobile C-arms market in the U.S. held the largest share in the North America region in 2025. The fixed and mobile C-arms marketin the U.S. dominated the market in the North American region. This is attributed to the presence of major manufacturers, which ensures the availability of advanced products and technologies. In addition, the increasing adoption of C-arms in the U.S. is driven by the growing demand for surgical procedures and the need for advanced imaging solutions to support complex surgeries across various medical specialties.
Europe Fixed And Mobile C-arms Market Trends
The fixed and mobile C-arms market in Europe held a significant market share in 2025, driven by the presence of key market players and their regional strategic initiatives, such as product introductions and technological innovations. For instance, in July 2022, Fujifilm Europe launched a new hybrid C-arm and portable X-ray device, further enhancing the range of advanced imaging solutions available. These initiatives and the increasing demand for high-quality imaging solutions in medical procedures contribute to market growth.
The UK fixed and mobile C-arms market is experiencing significant growth, driven by the country's increasing incidence of chronic disorders. As conditions such as cardiovascular diseases, musculoskeletal disorders, and neurological conditions become more prevalent, the demand for advanced imaging solutions like C-arms to support accurate diagnosis and treatment is rising. For instance, data published by the British Heart Foundation in September 2024 indicates that approximately 6.4 million people in England live with heart and circulatory diseases.
The fixed and mobile C-arms market in France is expected to grow over the forecast period, with technological advancements playing a significant role in driving the adoption of these devices. Innovations such as enhanced imaging quality, integration of 3D imaging, AI, and portability are making C-arms more efficient and accessible for a wider range of medical applications.
Germany fixed and mobile C-arms market is experiencing significant growth, driven by the increasing prevalence of chronic diseases, a strong healthcare infrastructure, and advancements in medical imaging technology. The rising incidence of conditions like cardiovascular diseases, orthopedic disorders, and neurological conditions is fuelling the demand for advanced imaging solutions to support accurate diagnosis and minimally invasive surgeries.
Asia Pacific Fixed And Mobile C-arms Market Trends
The fixed and mobile C-arms market in Asia Pacific is expected to witness the fastest growth of CAGR 5.5% over the forecast period. This growth is primarily driven by the expanding healthcare markets in countries like Japan, China, and India. The increasing burden of chronic diseases, such as cardiovascular conditions, orthopedic disorders, and cancer, is contributing to the rising demand for advanced imaging technologies in these regions. Furthermore, growing awareness among the population about the benefits of medical devices, along with improvements in healthcare infrastructure and access to advanced technologies, is fueling the adoption of fixed and mobile C-arms in the Asia Pacific.
China fixed and mobile C-arms market is expected to grow at a steady rate over the forecast period. This growth is primarily driven by the rising demand for advanced diagnostic tools and therapeutic devices, supported by the country’s aging population and increasing healthcare awareness. Moreover, ongoing investments in healthcare infrastructure and technology, along with government initiatives to enhance medical services, are likely to boost the adoption of C-arms in China.
The fixed and mobile C-arms market in Japan is significantly driven by growing initiatives. For instance, in July 2024, FUJIFILM Holdings Corporation is set to issue a JPY 200 billion social bond offering, the largest social bond offering in Japan's corporate bond market. The funds raised from this offering will be allocated to expanding the company's biopharmaceutical contract development and manufacturing (Bio CDMO) business, helping to meet unmet medical needs and enhance global access to medicines.
Latin America Fixed And Mobile C-arms Market Trends
The fixed and mobile C-arms market in Latin America is expected to growowing to the increasing adoption of medical systems in the region. As the population becomes more aware of healthcare options, the demand for advanced diagnostic and treatment technologies, including C-arms, is rising. This growing awareness about the benefits of early diagnosis and effective treatment, along with improvements in healthcare infrastructure, is driving the adoption of advanced medical systems in the region.
Middle East & Africa Fixed And Mobile C-arms Market Trends
The fixed and mobile C-arms market in the Middle East and Africa is experiencing notable growth, driven by various government initiatives to improve healthcare infrastructure and access to advanced medical technologies. Governments in the region are increasingly investing in healthcare development and supporting the adoption of innovative medical devices to enhance diagnostic and treatment capabilities. These efforts and the rising demand for accurate imaging in surgical procedures fuel the growth of the region's fixed and mobile C-arms market.
Key Fixed And Mobile C-arms Company Insights
The fixed and mobile C-arms industry players actively focus on strategies such as product innovation and technological advancements and expand their product portfolios to strengthen their market position. Many companies are investing in research and development to introduce advanced C-arm systems with improved image quality, enhanced mobility, and reduced radiation exposure. Furthermore, market players engage in partnerships, collaborations, and acquisitions to broaden their reach, access new markets, and meet the growing demand for advanced diagnostic and surgical solutions. These efforts are driving the overall growth of the fixed and mobile C-arms market.
Key Fixed And Mobile C-arms Companies:
The following key companies have been profiled for this study on the fixed and mobile c-arms market.
- GE HealthCare
- Koninklijke Philips N.V.
- Siemens Healthineers AG
- Medtronic
- Shimadzu Corporation
- Hologic, Inc.
- Canon Medical Systems Corporation
- Fujifilm Holdings Corporation
- Ziehm Imaging GmbH
Competitive Benchmarking
Category
Operating Strategies
Competitive Edge
Weakness
Established Players (GE HealthCare; Koninklijke Philips N.V.; Siemens Healthineers AG; Medtronic)
- Focus on expanding comprehensive fixed and mobile C-arm portfolios including fixed C-arms, mobile C-arms, mini C-arms, flat-panel detector systems, hybrid operating room imaging solutions, 3D imaging platforms, and AI-enabled image-guided intervention technologies. Strengthen strategic partnerships with hospitals, ambulatory surgical centers, orthopedic surgeons, cardiovascular specialists, neurosurgeons, and interventional radiologists to enhance technology adoption and long-term market penetration. Invest heavily in product innovation, clinical validation, physician training programs, dose reduction technologies, advanced visualization software, and digital surgery integration to support growing demand for minimally invasive and image-guided procedures.
- Strong brand recognition, extensive installed bases across hospitals, surgical centers, and interventional suites support market leadership. Large-scale clinical experience, advanced imaging expertise, established regulatory capabilities, and long-standing relationships with healthcare providers provide significant competitive advantages. Broad medical imaging portfolios covering fluoroscopy, radiology, CT, MRI, ultrasound, and image-guided surgery facilitate cross-selling opportunities and strengthen customer loyalty.
- Large organizations often experience slower innovation cycles due to extensive product validation, regulatory compliance, and portfolio management requirements. Premium pricing strategies may limit adoption in cost-sensitive healthcare settings and emerging markets. Dependence on capital equipment procurement cycles, hospital budget allocations, and healthcare infrastructure investments can constrain market expansion in certain regions.
Emerging Players (Canon Medical Systems Corporation; Fujifilm Holdings Corporation; Ziehm Imaging GmbH)
- Focus on specialized C-arm innovations including compact mobile imaging systems, advanced flat-panel detector technologies, AI-assisted imaging platforms, low-dose fluoroscopy solutions, portable surgical imaging systems, and workflow-enhancing digital visualization technologies. Develop cost-effective alternatives to conventional C-arm systems while emphasizing image quality, mobility, connectivity, ergonomic design, and procedural efficiency. Support market growth through targeted product development, physician education initiatives, strategic partnerships, and expansion into outpatient and specialty care settings.
- Faster innovation cycles and greater operational flexibility enable rapid development of next-generation imaging technologies and digital surgical solutions. Specialized expertise in mobile imaging, image processing, flat-panel detector technology, and clinician-focused system design provides differentiation. Their ability to address niche procedural requirements, improve workflow efficiency, and deliver technologically advanced solutions supports targeted market positioning and customer satisfaction.
- Limited financial resources, narrower product portfolios, and smaller commercial infrastructures compared with multinational imaging equipment manufacturers may restrict large-scale commercialization efforts. Lower brand awareness in certain regions, dependence on distributor networks, and limited economies of scale can affect competitiveness. Regulatory approval requirements, pricing pressures, and intense competition from established imaging companies may further challenge long-term growth and market penetration.
Recent Developments
-
In February 2024, Philips introduced the Philips Image Guided Therapy Mobile C-arm System 9000 - Zenition 90 Motorized, designed to assist surgeons in providing high-quality care to a larger number of patients.
-
In June 2023, GE HealthCare signed a distribution agreement with DePuy Synthes, the orthopedics division of Johnson & Johnson, to deliver GE HealthCare's OEC 3D Imaging System in combination with DePuy Synthes’ extensive product range, making it accessible to more surgeons and patients throughout the U.S.
-
In April 2022, Medtronic and GE Healthcare announced a collaboration to address the specific needs and demands of care in Ambulatory Surgery Centers (ASCs) and Office-Based Labs (OBLs). Customers can access a comprehensive range of products, financial solutions, and outstanding service through this partnership.
Fixed And Mobile C-arms Market Report Scope
Report Attribute
Details
Market size in 2025
USD 3.4 billion
Estimated market size in 2026
USD 3.6 billion
Projected market size by 2040
USD 4.9 billion
Growth rate
CAGR of 4.5% from 2026 to 2040
Historical data
2021 - 2024
Forecast period
2026 - 2040
Quantitative units
Revenue in USD million/billion and CAGR from 2026 to 2040
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Product, application, region
Regional scope
North America; Europe; Asia Pacific; Latin America; MEA
Country scope
U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway: Japan; China India; Australia; Thailand; South Korea; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait
Key companies profiled
GE HealthCare; Koninklijke Philips N.V.; Siemens Healthineers AG; Medtronic; Shimadzu Corporation; Hologic, Inc.; Canon Medical Systems Corporation; Fujifilm Holdings Corporation; Ziehm Imaging GmbH
Customization scope
Free report customization (equivalent up to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
Global Fixed And Mobile C-arms Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global fixed and mobile C-arms market report based on product, application, end use, and region:

-
Product Outlook (Revenue, USD Million, 2021 - 2033)
-
Fixed C-arms
-
Mobile C-arms
-
Full-size C-arms
-
Mini C-arms
-
-
-
Application Outlook (Revenue, USD Million, 2021 - 2033)
-
Orthopedics and Trauma
-
Drug delivery
-
Cardiovascular
-
Pain Management
-
Gastroenterology
-
Others
-
-
End Use Outlook (Revenue, USD Million, 2021 - 2033)
-
Hospitals
-
Ambulatory Surgical Centers
-
Research Institutions
-
-
Regional Outlook (Revenue, USD Million, 2021 - 2033)
-
North America
-
U.S.
-
Canada
-
-
Europe
-
UK
-
Germany
-
France
-
Italy
-
Spain
-
Denmark
-
Sweden
-
Norway
-
-
Asia Pacific
-
Japan
-
China
-
India
-
Australia
-
Thailand
-
South Korea
-
-
Latin America
-
Brazil
-
Mexico
-
Argentina
-
-
Middle East & Africa
-
South Africa
-
Saudi Arabia
-
UAE
-
Kuwait
-
-
Research Methodology
The fixed and mobile c-arms market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing - reconciling supply-side and demand-side estimates - and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each fixed and mobile c-arms segment quantified using the revenue-capture definitions in the table below.
Segment Definition
Segment - Product
Revenue capture definition
Fixed C-arms
Revenue generated from permanently installed C-arm imaging systems utilized in hybrid operating rooms, cardiovascular suites, vascular intervention centers, and advanced surgical facilities. This segment includes equipment sales, imaging software, installation services, maintenance contracts, upgrades, and associated accessories.
Digital C-arms
Revenue generated from portable C-arm imaging systems used across operating rooms, ambulatory surgical centers, trauma units, and specialty clinics. This includes full-size mobile C-arms, mini C-arms, flat-panel detector systems, software solutions, accessories, service agreements, and replacement components.
Segment - Application
Revenue capture definition
Orthopedics and Trauma
Revenue generated from the use of fixed and mobile C-arm systems in orthopedic and trauma procedures, including fracture fixation, joint replacement surgeries, spinal stabilization, trauma interventions, sports injury management, and orthopedic implant positioning.
Neurosurgery
Revenue generated from C-arm systems utilized during neurosurgical procedures such as spinal surgeries, vertebral fixation, minimally invasive spine interventions, neurovascular procedures, and cranial operations requiring real-time intraoperative imaging guidance.
Cardiovascular
Revenue generated from C-arm systems used in cardiac and vascular interventions, including angiography, angioplasty, stent placement, electrophysiology procedures, transcatheter interventions, peripheral vascular procedures, and hybrid cardiovascular surgeries.
Pain Management
Revenue generated from C-arm systems utilized in pain management procedures such as epidural steroid injections, nerve blocks, facet joint injections, radiofrequency ablation procedures, spinal pain interventions, and other image-guided pain therapies.
Gastroenterology
Revenue generated from C-arm systems used in gastroenterology procedures including ERCP (Endoscopic Retrograde Cholangiopancreatography), biliary interventions, gastrointestinal stenting, feeding tube placements, and other fluoroscopy-guided digestive system procedures.
Others
Revenue generated from C-arm applications across additional specialties including urology, oncology, pulmonology, gynecology, vascular surgery, general surgery, interventional radiology, emergency medicine, and veterinary applications. This segment also includes revenue from emerging image-guided procedures not classified within the primary application categories.
Estimation Model
Stage
Key Question
Process Steps
Data Sources
Scope Definition
What is being sized?
Define fixed and mobile C-arm product categories.
Segment the market.
Establish geographic boundaries (Global, North America, Europe, Asia-Pacific, Latin America, and MEA).
Align on base year & forecast horizon (2026-2033).
Industry publications, healthcare association reports
Build the Product Base
How large is total addressable market?
Assess procedure volumes.
Evaluate the number of hospitals, operating rooms, hybrid operating rooms, ambulatory surgical centers, and specialty clinics globally.
Estimate adoption of advanced imaging technologies, including flat-panel detectors and AI-assisted imaging systems.
Forecast future demand based on surgical volume growth and healthcare infrastructure expansion.
Hospital registries, imaging center databases, healthcare facility records, company filings
Estimate Penetration
What portion is transitioning to next-generation smart systems?
Analyze adoption rates across hospitals, surgical centers, orthopedic practices, and interventional suites.
Assess regional differences in healthcare infrastructure, capital expenditure, and imaging technology adoption.
Examine equipment replacement demand and procurement trends.
Validate estimates through primary interviews, distributor feedback, and manufacturer sales data.
Primary interviews, company filings, trade surveys
Revenue Conversion
How does unit volume become market revenue?
Collect average selling prices of fixed C-arms, mobile C-arms, mini C-arms, imaging software, accessories, and service contracts.
Assess recurring revenue from maintenance, upgrades, software licenses, and replacement components.
Estimate manufacturer market shares and pricing trends.
Triangulate and validate.
Hospital procurement/vendor archives, distributor pricing sheets, import/export databases
Delivered Customizations
This report has been delivered with the following In-depth customizations
Client Request
Customization Delivered
Value Adds
Competitive Landscape Analysis
Conducted a comprehensive competitive landscape assessment for the wearable injectors market, covering on-body injectors, patch injectors, large-volume wearable injectors, connected drug delivery devices, and drug-device combination systems. The study evaluated company positioning, product portfolio differentiation, technological innovations, regulatory approvals, strategic collaborations, manufacturing capabilities, intellectual property strength, distribution networks, and geographic expansion initiatives. It benchmarked leading drug delivery companies and emerging wearable injector developers to identify market share dynamics, innovation trends, partnership opportunities, and competitive factors influencing adoption.
Enables stakeholders to understand competitive dynamics, benchmark technology capabilities, evaluate product differentiation strategies, identify acquisition and partnership opportunities, and strengthen market positioning within the advanced drug delivery ecosystem.
Segment by Product Analysis
Conducted a detailed segment-level analysis across on-body injectors, off-body injectors, disposable wearable injectors, reusable wearable injectors, and connected delivery systems. The study assessed adoption trends, patient preferences, drug compatibility, pricing dynamics, commercialization activities, and technology advancements across each segment. It further evaluated emerging innovations including smart connectivity, remote monitoring, dose tracking, automated drug delivery, and integration with biologic therapies influencing future market growth.
Enables stakeholders to identify high-growth product categories, understand evolving patient and clinician preferences, evaluate innovation opportunities, assess competitive intensity within individual segments, and align product development and commercialization strategies with future market demand.
Macroeconomic Analysis
Conducted an in-depth assessment of macroeconomic, demographic, healthcare, and regulatory factors influencing the wearable injectors market, including the rising prevalence of chronic diseases, growing biologics adoption, aging populations, healthcare expenditure growth, homecare expansion, and increasing demand for patient-centric drug delivery solutions. The study analyzed reimbursement policies, regulatory developments, pharmaceutical pipeline trends, healthcare infrastructure, and technological advancements affecting market growth. Additionally, it evaluated the impact of self-administration trends, value-based healthcare models, and digital health integration on wearable injector adoption.
Enables stakeholders to understand the major healthcare, economic, demographic, and regulatory factors driving or restraining market growth. The analysis supports strategic planning, investment prioritization, market entry decisions, pricing optimization, risk assessment, and long-term growth strategies across regional and global wearable injectors markets.
Frequently Asked Questions About This Report
Some key players operating in the fixed and mobile C-arms market include GE HealthCare; Koninklijke Philips N.V.;Siemens Healthineers AG; Medtronic; Shimadzu Corporation ; Hologic, Inc.; Canon Medical Systems Corporation; Fujifilm Holdings Corporation; Ziehm Imaging GmbH
Key factors that are driving the fixed and mobile C-arms market growth include the growing number of surgical procedures and technological advancements in the development of novel C-arms.
North America dominated the fixed and mobile C-arms market with a share of 39.6% in 2025.
Asia Pacific is the fastest-growing region over the forecast period.
The orthopedics & trauma segment accounted for the largest market revenue share in 2025 and cardiovascular segment is projected to register the fastest growth rate during the forecast period.
The global fixed and mobile C-arms market size was valued at USD 3.4 billion in 2025 and is estimated at USD 3.6 billion for 2026.
The global fixed and mobile C-arms market is expected to grow at a CAGR of 4.5% from 2026 to 2033, reaching USD 4.9 billion by 2033.
The fixed C-arms segment led with a 59.1% revenue share in 2025, while the mobile C-arms segment is the fastest-growing.
About the Author(s)
Medical Devices Research Team
Healthcare · Medical DevicesThis report was authored by the medical devices research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the medical devices segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.
Last Updated:
Speak to Analyst
Customize this report to your needs — add regions, segments, or data points, with 20% free customization.
Or view our licence options:
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.